Predict your next investment

HEALTHCARE
n-tap.org

See what CB Insights has to offer

About Neurofibromatosis Therapeutic Acceleration Program

Neurofibromatosis Therapeutic Acceleration Program is dedicated to advancing treatment options for individuals with plexiform neurofibromas and cutaneous neurofibromas. In order to do this, it identifies the most promising opportunities to develop effective therapies, delivers support to develop these ideas, and removes obstacles to ensure patients benefit from research advances. NTAP uses a collaborative approach that brings together patients, clinicians, researchers, industry, and government to determine where resources are most effectively deployed to produce treatments.

Neurofibromatosis Therapeutic Acceleration Program Headquarter Location

600 North Wolfe Street Meyer 100

Baltimore, Maryland, 21287,

United States

410-955-8016

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Neurofibromatosis Therapeutic Acceleration Program Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Neurofibromatosis Therapeutic Acceleration Program Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.